NaturalShrimp Incorporated Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)	Total	Common Stock	Additional Paid-In Capital	Stock Payable [Member]	Retained Earnings (Accumulated Deficit)	Noncontrolling Interest	Series A Preferred Stock [Member]	Series B Preferred Stock [Member]
Balance, shares at Mar. 31, 2020		379,742,524					5,000,000	2,250
Balance, amount at Mar. 31, 2020	$ (2,937,780)	$ 37,975	$ 43,533,243	$ 0	$ (46,427,396)	$ (82,101)	$ 500
Issuance of common stock upon conversion, shares		37,926,239
Issuance of common stock upon conversion, amount	226,437	$ 3,793	222,644
Reclass of derivative liability upon conversion or redemption of related convertible debentures	205,000		205,000
Purchase of Series B Preferred shares, shares								1,250
Purchase of Series B Preferred shares, amount	1,250,000		1,250,000
Beneficial conversion feature related to the Series B Preferred Shares			293,000		(293,000)			$ 0
Dividends payable on Series B PS	(144,792)				(144,792)
Series B PS Dividends in kind issued, shares								50
Series B PS Dividends in kind issued, amount	56,458		56,458
Conversion of Series B PS to common stock, shares		33,569,730						(800)
Conversion of Series B PS to common stock, amount		$ 3,357	(3,357)					$ 0
Common stock issued in Vista Warrant settlement, shares		17,500,000
Common stock issued in Vista Warrant settlement, amount	610,000	$ 1,750	608,250
Reclass of warrant liability upon the cancellation of warrants under Vista Warrant settlement	90,000		90,000
Common stock issued to consultant, shares		1,250,000
Common stock issued to consultant, amount	61,250	$ 125	61,125
Net loss	(477,072)				(477,072)
Balance, shares at Jun. 30, 2020		469,988,493					5,000,000	2,750
Balance, amount at Jun. 30, 2020	(1,060,499)	$ 47,000	46,316,363	0	(47,342,260)	(82,101)	$ 500	$ 0
Balance, shares at Mar. 31, 2021		560,745,180					5,000,000	607
Balance, amount at Mar. 31, 2021	3,070,969	$ 56,076	56,649,491	136,000	(53,683,268)	(87,830)	$ 500	$ 0
Issuance of common stock upon conversion, shares		1,329,246
Issuance of common stock upon conversion, amount	421,486	$ 133	421,353
Conversion of Series B PS to common stock, shares		3,144,000						(262)
Conversion of Series B PS to common stock, amount	0	$ 314	(314)					$ 0
Common stock issued to consultant, shares		125,000
Common stock issued to consultant, amount	73,651	$ 13	48,738	24,900
Net loss	(2,562,743)				(2,562,743)
Conversion of Series D PS to common stock, shares		428,572
Conversion of Series D PS to common stock, amount	0	$ 43	(43)					$ 0
Exchange of Series D PS to Series E PS	(3,258,189)				(3,258,189)
Sale of common shares and warrants for cash, less offering costs and commitment shares, shares		35,772,729
Sale of common shares and warrants for cash, less offering costs and commitment shares, amount	17,277,223	$ 3,577	17,273,546
Exercise of warrants related to the sale of common shares, shares		1,100,000
Exercise of warrants related to the sale of common shares, amount	11,000	$ 110	10,890
Beneficial conversion feature related to the Series E Preferred Shares	3,269,505		3,269,505
Amortization of beneficial conversion feature related to Series E Preferred Shares	(817,376)				(817,376)
Redemption of Series D Preferred shares	(2,534,758)				(2,534,758)
Amortization of beneficial conversion feature related to Series D Preferred Shares	0
Commitment shares issued with Series D Preferred Shares	0
Common shares to be issued for the acquisition of the non-controlling interest subsidiary's remaining equity	(1,000,000)		(3,087,830)	2,000,000		87,830
Common shares to be issued for Patent acquisition	5,000,000			5,000,000
Balance, shares at Jun. 30, 2021		602,644,727					5,000,000	345
Balance, amount at Jun. 30, 2021	$ 18,950,768	$ 60,266	$ 74,585,336	$ 7,160,900	$ (62,856,334)	$ 0	$ 500	$ 0